�Covidien (NYSE: COV, BSX: COV), a world leader in advanced energy-based surgical systems, today announced the global release of the Evident� microwave ablation organisation. Physicians now have a powerful new tool with industry-leading engineering to ablate soft tissue.
The Evident� microwave ablation system received 510(k) clearance from the United States Food and Drug Administration for use in soft tissue, and is now the first microwave ablation system available globally.
The Evident� microwave ablation system is intended for coagulation of soft tissue during transdermic, laparoscopic and open surgical procedures. Microwave energy emanates from the feed point of the radiating section of the antenna, causation coagulation of the tissue. The system then creates heat by generating rubbing through the vibration of water molecules. With microwave ablation, in that respect is no current flow through the patient, eliminating the motivation for grounding pads.
"We are extremely excited to offer the Evident� microwave ablation organization to physicians throughout the world," said Christopher Carlton, Vice President and General Manager, Interventional Oncology, Covidien. "As the only company to offer both microwave and radiofrequency ablation systems, we check the Evident� system as a significant new tool in a doctor's arsenal, which can positively lend to better patient outcomes."
With today's launch, physicians will today have approach to a unique system for tissue paper ablation. Microwave technology has shown bright results in ablating soft tissue in patients world Health Organization are non candidates for surgical resection and have few leftover treatment options.
"Microwave engineering has allowed me to treat patients with bigger ablations and more promptly compared to radiofrequency," aforementioned Anton Bilchik, M.D., Medical Director of the California Oncology Research Institute and Clinical Professor of Medicine at UCLA School of Medicine. "This system provides physicians with efficient and fast ablation."
This major technological advance allows surgical oncologists, interventional radiologists, hepatobiliary surgeons and other medical specialists to perform percutaneous, laparoscopic or open operative soft tissue ablation, and in less time than other forms of excision - the Evident� microwave ablation system can take 10 minutes or less. The speed and efficiency of the Evident� microwave ablation system may miserly less time in the operating or radiology suite and less time that patients will spend under anesthesia.
Robert Martin, M.D., Associate Professor of Surgery, Division of Surgical Oncology at the University of Louisville James Graham Brown Cancer Center added, "Compared to former ablative systems, this microwave system has a more efficient heat mechanism. This leads to faster, more efficient ablations that potty be performed simultaneously, and thus leads to less time under anesthesia for the affected role."
About Covidien
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2007 tax income of intimately $9 gazillion, Covidien has more than 42,000 employees planetary in 57 countries, and its products are sold in over 130 countries.
Covidien
More info
